Feb 17 (Reuters) - Medtronic surpassed Wall Street expectations for third-quarter profit and revenue on Tuesday, buoyed by ...
Medtronic saw Street-beating third-quarter results fueled by the success of its pulsed-field ablation technologies for treating AFib.
Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday, buoyed by strong demand for its heart ...
Within diversified index frameworks such as the s&p 500 index, healthcare technology firms are evaluated for both defensive ...
General view of the logo of Medtronic, a healthcare technology and pharmaceutical company, seen at their plant, in Galway, Ireland, April 11, 2025. REUTERS/Clodagh Kilcoyne (Reuters) -Medical device ...
Cybersecurity vulnerabilities in certain Medtronic CareLink programmers are at the center of the recent voluntary recall. (This story has been updated with an FDA statement.) See Also: A Legal ...
The FDA issued a Class I recall — the most serious recall classification — for some of Medtronic’s cardiac resynchronization therapy and implantable cardioverter defibrillators. Here are four things ...
Feb 3 (Reuters) - Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued ‌at up to $585 million, as it looks to ‌bolster its heart devices portfolio by adding a new ...
Investing.com -- Barclays reinstated coverage of Medtronic with an Overweight rating and a $116 price target ahead of the company’s fiscal third-quarter results on Monday, citing strong growth in ...
CHICAGO (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that shocks the ...
CHICAGO (Reuters) - Medtronic Inc said on Tuesday a study of device therapy in patients with mild heart failure missed its primary goal on a measure of disease progression, but some patients saw their ...
Feb 17 (Reuters) - Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday, buoyed by strong demand ...